FibroBiologics, Inc. Common Stock Financial Flexibility Index
FibroBiologics, Inc. Common Stock financial flexibility index. FibroBiologics, Inc. Common Stock (FBLG) has a Financial Flexibility Index of -0.46x as of September 2025. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $6.00K) represents 0% of total liabilities ($8.62 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of FibroBiologics, Inc. Common Stock (2022–2025)
Financial flexibility index of FibroBiologics, Inc. Common Stock from 2022 to 2025. Historical Financial Flexibility Index trend for FibroBiologics, Inc. Common Stock across 4 annual periods. Check FibroBiologics, Inc. Common Stock (FBLG) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
FibroBiologics, Inc. Common Stock Financial Flexibility Index by Year (2022–2025)
FibroBiologics, Inc. Common Stock financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for FibroBiologics, Inc. Common Stock. For the full cash flow conversion analysis, see FibroBiologics, Inc. Common Stock (FBLG) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.85x | $-11.72 Million | $-11.90 Million | $13.71 Million | ▼ -52.9% |
| 2024 | -0.56x | $-5.91 Million | $-6.40 Million | $10.57 Million | ▼ -21.2% |
| 2023 | -0.46x | $-4.07 Million | $-4.07 Million | $8.82 Million | ▲ +42.5% |
| 2022 | -0.80x | $-1.41 Million | $-1.41 Million | $1.76 Million | — |